Phio Pharma Analyst Ratings

BenzingaFeb 19 11:25 ET · Ratings

Positive Outlook for Phio Pharmaceuticals: Promising Clinical Results and Innovative Technology Drive Buy Rating

TipRanksFeb 19 09:35 ET · Ratings

H.C. Wainwright Maintains Phio Pharmaceuticals(PHIO.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsFeb 19 09:33 ET · Ratings

Phio Pharmaceuticals Showcases New Cancer-Fighting Gene Therapy at Industry Event

BenzingaFeb 3 07:50 ET

Express News | Phio Pharmaceuticals Corp Files for Offering of up to 5.93 Mln Common Shares by the Selling Stockholders - SEC Filing

ReutersJan 21 16:40 ET

Optinose OPTN +20% Preliminary Product Revenue; Phio Pharmaceuticals PHIO -26% Offering

BioPharmCatalystJan 15 16:30 ET